Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant BA.2 has spread in many countries, replacing the earlier Omicron subvariant BA.1 and other variants. Here, using a cell culture infection assay, we quantified the intrinsic sensitivity of BA.2 and BA.1 compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Hirofumi, Hishiki, Takayuki, Akazawa, Daisuke, Kim, Kwang Su, Woo, Joohyeon, Shionoya, Kaho, Tsuchimoto, Kana, Iwanami, Shoya, Moriyama, Saya, Kinoshita, Hitomi, Yamada, Souichi, Kuroda, Yudai, Yamamoto, Tsukasa, Kishida, Noriko, Watanabe, Shinji, Hasegawa, Hideki, Ebihara, Hideki, Suzuki, Tadaki, Maeda, Ken, Fukushi, Shuetsu, Takahashi, Yoshimasa, Iwami, Shingo, Watashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251960/
https://www.ncbi.nlm.nih.gov/pubmed/35798223
http://dx.doi.org/10.1016/j.antiviral.2022.105372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251960/
https://www.ncbi.nlm.nih.gov/pubmed/35798223
http://dx.doi.org/10.1016/j.antiviral.2022.105372

Ejemplares similares